167 related articles for article (PubMed ID: 14575804)
1. A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury.
Ogata M; Iwamoto T; Tazawa N; Nishikawa M; Yamashita J; Takaoka M; Matsumura Y
Eur J Pharmacol; 2003 Oct; 478(2-3):187-98. PubMed ID: 14575804
[TBL] [Abstract][Full Text] [Related]
2. SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models.
Matsuda T; Arakawa N; Takuma K; Kishida Y; Kawasaki Y; Sakaue M; Takahashi K; Takahashi T; Suzuki T; Ota T; Hamano-Takahashi A; Onishi M; Tanaka Y; Kameo K; Baba A
J Pharmacol Exp Ther; 2001 Jul; 298(1):249-56. PubMed ID: 11408549
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries.
Takahashi K; Takahashi T; Suzuki T; Onishi M; Tanaka Y; Hamano-Takahashi A; Ota T; Kameo K; Matsuda T; Baba A
Eur J Pharmacol; 2003 Jan; 458(1-2):155-62. PubMed ID: 12498920
[TBL] [Abstract][Full Text] [Related]
4. Pre- or post-ischemic treatment with a novel Na+/Ca2+ exchange inhibitor, KB-R7943, shows renal protective effects in rats with ischemic acute renal failure.
Yamashita J; Itoh M; Kuro T; Kobayashi Y; Ogata M; Takaoka M; Matsumura Y
J Pharmacol Exp Ther; 2001 Feb; 296(2):412-9. PubMed ID: 11160625
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of ischemia/reperfusion-induced renal injury in mice deficient in Na+/Ca2+ exchanger.
Yamashita J; Kita S; Iwamoto T; Ogata M; Takaoka M; Tazawa N; Nishikawa M; Wakimoto K; Shigekawa M; Komuro I; Matsumura Y
J Pharmacol Exp Ther; 2003 Jan; 304(1):284-93. PubMed ID: 12490603
[TBL] [Abstract][Full Text] [Related]
6. KB-R7943, a selective Na+/Ca2+ exchange inhibitor, protects against ischemic acute renal failure in mice by inhibiting renal endothelin-1 overproduction.
Yamashita J; Ogata M; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2001 Mar; 37(3):271-9. PubMed ID: 11243417
[TBL] [Abstract][Full Text] [Related]
7. Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs.
Takahashi T; Takahashi K; Onishi M; Suzuki T; Tanaka Y; Ota T; Yoshida S; Nakaike S; Matsuda T; Baba A
Eur J Pharmacol; 2004 Nov; 505(1-3):163-8. PubMed ID: 15556149
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of KB-R7943, a novel Na+/Ca2+ exchange inhibitor, on ischemic acute renal failure in rats.
Kuro T; Kobayashi Y; Takaoka M; Matsumura Y
Jpn J Pharmacol; 1999 Oct; 81(2):247-51. PubMed ID: 10591486
[TBL] [Abstract][Full Text] [Related]
9. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
Feng NC; Satoh H; Urushida T; Katoh H; Terada H; Watanabe Y; Hayashi H
J Cardiovasc Pharmacol; 2006 Feb; 47(2):263-70. PubMed ID: 16495765
[TBL] [Abstract][Full Text] [Related]
10. Effects of SEA0400, a Na+/Ca2+ exchange inhibitor, on ventricular arrhythmias in the in vivo dogs.
Nagasawa Y; Zhu BM; Chen J; Kamiya K; Miyamoto S; Hashimoto K
Eur J Pharmacol; 2005 Jan; 506(3):249-55. PubMed ID: 15627435
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory profile of SEA0400 [2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] assessed on the cardiac Na+-Ca2+ exchanger, NCX1.1.
Lee C; Visen NS; Dhalla NS; Le HD; Isaac M; Choptiany P; Gross G; Omelchenko A; Matsuda T; Baba A; Takahashi K; Hnatowich M; Hryshko LV
J Pharmacol Exp Ther; 2004 Nov; 311(2):748-57. PubMed ID: 15231867
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 aggravates hypoxia/reoxygenation-induced injury in renal epithelial cells through the activation of a Na+/Ca2+ exchanger.
Iwamoto T; Kita S; Katsuragi T
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S462-6. PubMed ID: 15838349
[TBL] [Abstract][Full Text] [Related]
13. Anesthetic preconditioning enhances Ca2+ handling and mechanical and metabolic function elicited by Na+-Ca2+ exchange inhibition in isolated hearts.
An J; Rhodes SS; Jiang MT; Bosnjak ZJ; Tian M; Stowe DF
Anesthesiology; 2006 Sep; 105(3):541-9. PubMed ID: 16931987
[TBL] [Abstract][Full Text] [Related]
14. Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents.
Tanaka H; Nishimaru K; Aikawa T; Hirayama W; Tanaka Y; Shigenobu K
Br J Pharmacol; 2002 Mar; 135(5):1096-100. PubMed ID: 11877314
[TBL] [Abstract][Full Text] [Related]
15. The Na+/Ca2+ exchange inhibitor SEA0400 limits intracellular Ca2+ accumulation and improves recovery of ventricular function when added to cardioplegia.
Egar J; Ali A; Howlett SE; Friesen CH; O'Blenes S
J Cardiothorac Surg; 2014 Jan; 9():11. PubMed ID: 24401610
[TBL] [Abstract][Full Text] [Related]
16. SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.
Wang J; Zhang Z; Hu Y; Hou X; Cui Q; Zang Y; Wang C
Physiol Res; 2007; 56(1):17-23. PubMed ID: 16497099
[TBL] [Abstract][Full Text] [Related]
17. Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943.
Magee WP; Deshmukh G; Deninno MP; Sutt JC; Chapman JG; Tracey WR
Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H903-10. PubMed ID: 12446284
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effect of SEA0400, a selective inhibitor of the Na(+)/Ca(2+) exchanger, on myocardial ischemia-reperfusion injury in rats.
Yoshiyama M; Nakamura Y; Omura T; Hayashi T; Takagi Y; Hasegawa T; Nishioka H; Takeuchi K; Iwao H; Yoshikawa J
J Pharmacol Sci; 2004 Jun; 95(2):196-202. PubMed ID: 15215644
[TBL] [Abstract][Full Text] [Related]
19. Effects of SEA0400 and KB-R7943 on Na+/Ca2+ exchange current and L-type Ca2+ current in canine ventricular cardiomyocytes.
Birinyi P; Acsai K; Bányász T; Tóth A; Horváth B; Virág L; Szentandrássy N; Magyar J; Varró A; Fülöp F; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):63-70. PubMed ID: 16086157
[TBL] [Abstract][Full Text] [Related]
20. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: pharmacology of SEA0400, a specific inhibitor of the Na(+)-Ca(2+) exchanger.
Matsuda T; Koyama Y; Baba A
J Pharmacol Sci; 2005 Mar; 97(3):339-43. PubMed ID: 15764845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
